Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Global transcriptomics analysis for TDO2 alteration in human triple-negative breast cancer cell lines

ABSTRACT: To elucidate the downstream transcriptomics changes in reponse to TDO2 alteration including shRNA knockdown, overexpression and TDO2/IDO duak inhibitor treatments in human triple-negative breast cancer cell lines.

ORGANISM(S): Homo sapiens

PROVIDER: GSE253237 | GEO | 2025/01/02

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Global transcriptomics analysis for TDO2 alteration in human triple-negative breast cancer cell lines

Project description:Global transcriptomics analysis for TDO2 alteration in human triple-negative breast cancer cell lines

| PRJNA1064872 | ENA

Effect of TDO2/IDO dual inhibitor AT0174 on human MDA-MB-453 breast cancer cells

Project description:To investigate global transcriptomics of human MDA-MB-453 breast cancer cells in response to the TDO2/IDO dual inhibitor AT0174 treatment in compared with the vehicle control

2025-01-02 | GSE253238 | GEO

In Vivo inhibition of TDO2 in fibroids results in widespread alteration in the tumor transcriptome

Project description:This study aimed to characterize large and small RNA transcriptomic changes in fibroid xenografts from mice treated with the TDO2 inhibitor 680C91 for two months.

2026-02-16 | GSE319228 | GEO

TDO2 promotes hepatocellular carcinoma by regulating tryptophan-kynurenine pathway

Project description:Objective: This study aims to investigate the impact of differentially expressed tryptophan 2,3-dioxygenase (TDO2) on hepatocellular carcinoma (HCC) growth and its role in regulating ADCY5 and PRKAR2B expression in cells and tissues. Methods: Serum amino acid profiles in patients with HCC were analyzed via metabolomics. Lentiviral transfection was used to knock down and overexpress TDO2 in cells, with corresponding subcutaneous tumor models established in nude mice. A rat model of primary hepatocellular carcinoma was generated through intraperitoneal injection of N-nitrosodiethylamine (DEN). Cellular responses were assessed using CCK8, Annexin V-PE/7ADD double staining, and scratch assays. Transcriptome sequencing was performed to analyze genetic alterations in subcutaneous tumor tissues, while RT-qPCR and Western blotting were employed to quantify mRNA and protein levels. Results: TDO2 knockdown inhibited hepatocellular carcinoma cell proliferation and migration, while promoting apoptosis. Conversely, TDO2 overexpression enhanced cell proliferation and migration. Moreover, ADCY5 overexpression reverses the tumor-suppressive effects elicited by TDO2 knockdown. Transcriptome sequencing revealed an association between TDO2 and the downstream genes ADCY5 and PRKAR2B. In both cellular and animal models, mRNA levels of ADCY5 and PRKAR2B were positively correlated with TDO2 expression. Conclusion: TDO2 may facilitate HCC growth and metastasis by activating ADCY5 expression and its downstream target PRKAR2B.

2025-10-10 | GSE309614 | GEO

In Vivo inhibition of TDO2 in fibroids results in widespread alteration in the tumor transcriptome

Project description:In Vivo inhibition of TDO2 in fibroids results in widespread alteration in the tumor transcriptome

| PRJNA1422639 | ENA

Effect of TDO2/IDO dual inhibitor AT0174 on human MDA-MB-453 breast cancer cells

Project description:Effect of TDO2/IDO dual inhibitor AT0174 on human MDA-MB-453 breast cancer cells

| PRJNA1064873 | ENA

Triple-negative breast cancer cell line MDA-MB-231 +/- CD43 knockdown

Project description:The triple-negative breast cancer cell line MDA-MB-231 with high CD43 expression was stably transfected with a vector expressing a non-functional shRNA or 4 of these same vectors each expressing a different shRNA targeting human CD43 mRNA. The transcriptomes of these two daughter lines were then compared by differential microarray analysis.

2021-05-04 | GSE173757 | GEO

Expression profiling of Tdo2 RNAi in C.elegans

Project description:Expression profiling of Tdo2 RNAi in C.elegans

| PRJEB13954 | ENA

Hypoxia and dimethyloxalylglycine (DMOG) downregulates tryptophan-2,3-dioxygenase (TDO2) expression in GBM cells

Project description:The tryptophan degrading enzyme TDO2 is downregulated upon HIF1alpha stabilization by exposure to both hypoxia as well as chemical hypoxia mimetics such as DMOG in glioblastoma cell line A172.

2019-12-29 | GSE138535 | GEO

Effect of depletion of YAP1 on gene expression in triple negative breast cancer

Project description:To investigate the cooperative function HJURP/YAP1/NDRG1 in the regulation of progression in triple negative breast cancer, we established MDA-MB-231 cell lines in which each target gene has been knocked down by shRNA. We then performed gene expression profiling analysis using data obtained from RNA-seq of 2 different cells.

2022-10-24 | GSE201877 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data